CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 13.7

ph-index = 11

Forward Citations = 349(Granted Patents)

Company Filing History:

12 out of 1,323

G.d. Searle & Company

patents

5 out of 200

Pharmacia Corporation

Pharmacia Corporation (of Pfizer, Inc.)

patents

Years Active: 2000-2014

Loading Chart...

19 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8633206 - Pyrrolo[2,3-D]pyrimidine compounds (2014-01-21),

2. 7153959 - Substituted pyrazoles as p38 kinase inhibitors (2006-12-26),

3. 7138411 - Substituted benzopyran derivatives for the treatment of inflammation (2006-11-21),

4. 7109211 - Substituted benzopyran derivatives for the treatment of inflammation (2006-09-19),

5. 7071198 - Substituted pyrazoles as p38 kinase inhibitors (2006-07-04),

6. 6979686 - Substituted pyrazoles as p38 kinase inhibitors (2005-12-27),

7. 6750338 - Process for making 5-substituted pyrazoles (2004-06-15),

8. 6617324 - Substituted pyrazoles as p38 kinase inhibitors (2003-09-09),

9. 6525059 - Substituted pyrazoles as p38 kinase inhibitors (2003-02-25),

10. 6514977 - Substituted pyrazoles as p38 kinase inhibitors (2003-02-04),

11. 6492390 - Substituted benzopyran analogs for the treatment of inflammation (2002-12-10),

12. 6482955 - Process for making 5-substituted pyrazoles (2002-11-19),

13. 6423713 - Substituted pyrazoles as p38 kinase inhibitors (2002-07-23),

14. 6342608 - Process for making substituted pyrazoles (2002-01-29),

15. 6271253 - Substituted benzopyran derivatives for the treatment of inflammation (2001-08-07),

Title: Susan J. Hartmann: Innovator in Pharmaceutical Compounds

Introduction: Susan J. Hartmann, based in Kirkwood, Missouri, is a notable inventor with an impressive portfolio of 19 patents. Her work primarily focuses on the development of pharmaceutical compounds that address critical medical conditions.

Latest Patents: Among her latest contributions to the field are the following patents:

1. Pyrrolo[2,3-D]pyrimidine compounds - This patent describes pyrrolo[2,3-d]pyrimidine compounds that serve as Janus Kinase (JAK) inhibitors, outlining their potential applications in pharmaceutical compositions and detailing methods for their preparation.

2. Substituted pyrazoles as p38 kinase inhibitors - This patent presents a class of pyrazole derivatives designed for treating disorders mediated by p38 kinase. The compounds of particular interest are defined by Formula IA.

Career Highlights: Susan has made significant contributions while working at renowned companies like G.D. Searle & Company and Pharmacia Corporation. Her innovative spirit and dedication to pharmaceutical research have driven advancements in medicinal chemistry and therapeutic development.

Collaborations: Throughout her career, Susan has collaborated with esteemed colleagues, including Suzanne S. Metz and Matthew James Graneto, contributing to a collaborative environment that fosters creativity and innovation in research and development.

Conclusion: Susan J. Hartmann stands out as an influential inventor in the pharmaceutical industry. Her innovative patents and collaborative efforts reflect her commitment to advancing healthcare solutions, making a lasting impact on medical science.

This text is generated by artificial intelligence and may not be accurate.